Pre-published methods

CIPAC Methods are available on a per-method basis, as long as they are not yet published in a Handbook. CIPAC charges a nominal fee per method.


Instructions
  • The list of pre-published methods below is exhaustive.
  • Tick the method or methods you wish to receive in the orderform. The methods are sent as pdf files attached to an e-mail - a working e-mail address is therefore mandatory.
  • Each method is charged with £5. Please sum the number of methods you wish to receive and calculate the grand total. Print the form duly filled and signed, to Marston Book Services (see details below) by fax.
  • As soon as you order is processed, you shall receive the pdf files by e-mail attachment.

Terms of Use
By ordering one or more of these methods, the user accepts the conditions of use as follows:

  • These are draft methods and are subject to revision without further notice.
  • These methods will appear in revised and edited form in CIPAC Handbook Q presumably in the year 2024. The pre-published methods expire as soon as they appear in printed form in the CIPAC Handbook Q.
  • The CIPAC copyright and disclaimer applies to all pre-published methods.

Available methods

First Name
Last Name
Countries
Capitals
616
Florasulam
The reversed phase HPLC method (CIPAC/5257) for the determination of florasulam in TC and SC formulations was accepted as full CIPAC method
(ISBN 978-1-911009-43-6).
Full
283
Metribuzin
The capillary gas chromatographic method with split injection, using dipentylphthalate as internal standard and helium as eluent (CIPAC/5253), for the determination of metribuzin in TC, SC, WG and WP formulations was accepted as full CIPAC method with the HorRat values resulted from the data sets using helium as eluent gas (ISBN 978-1-911009-44-3).
Full
641.202
Quizalop-P-ethyl
The chiral phase HPLC method (CIPAC/5255) for the determination of quizalofop-P-ethyl in TC and EC formulations was accepted as full CIPAC method, with additional modifications in the description of the method concerning the identity test (ISBN 978-1-911009-45-0).
Full
802
Spinetoram
The chiral phase HPLC method (CIPAC/5255) for the determination of quizalofop-P-ethyl in TC and EC formulations was accepted as full CIPAC method, with additional modifications in the description of the method concerning the identity test (ISBN 978-1-911009-45-0).
Full
1006
28-homobrassinolide
The reversed phase HPLC method (CIPAC/5269) for the determination of 28-homobrassinolide in TC, SL and EC formulations was accepted as a full CIPAC method (ISBN 978-1-911009-59-7).
Full
221
Chlorpyrifos
The reversed phase HPLC method (CIPAC/5277) for the determination of chlorpyrifos in TC and EC formulations was accepted as a full CIPAC method. (ISBN 978-1-911009-60-3)
Full
494
Tebuconazole
The extension of the scope (CIPAC/5287) of CIPAC method 494/WP/M/3 for the determination of the tebuconazole content in EC formulations was accepted as a full CIPAC method (ISBN 978-1-911009-57-3).
Full
133
Ametryn
The capillary GC method using internal standard (CIPAC/5265) for the determination of ametryn in TC, WG and SC formulations was accepted as a full CIPAC method (ISBN 978-1-911009-58-0).
Full
MT 190.1
Determination of Releas Properties
of lambda-Cyhalothrin
CS Formulations
The revision of the CIPAC MT 190, Determination of Release Properties of lambda-Cyhalothrin CS Formulations (CIPAC/5260) was accepted as full CIPAC method (ISBN 978-1-911009-47-4).
Full